[Halidor in the treatment of cerebral vascular diseases in emergency cases].
An aim of the study was to assess efficacy and safety of an injection form of galidor (bencyclan) in patients with chronic cerebral vascular diseases in cases of emergency. Sixty patients with discirculatory encephalopathy (DE), including 38 with basilar insufficiency, were treated. Mean age of patients was 59,7 years. Halidor was injected slowly intravenous in dosage 50 mg (13 patients) or 100 mg (56 patients) during 5 minutes. After treatment, the following symptoms were observed: sluggishness (2,8% of patients), excitement (0,9%), hyperhydrosis (0,9%), coordination disturbance (0,9%). Halidor does not cause side-effects and complications in 90% of patients. The results obtained suggest high efficacy of galidor in DE. A good effect has been achieved in 72,5% of cases, fair effect in 20,3%, no effect has been found in 7,2%.
Nevzorov
N M
NM
Razova
T G
TG
Markevich
Iu N
IuN
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001537:Bencyclane / Q000008:administration & dosage*; D001794:Blood Pressure / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004630:Emergencies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007275:Injections, Intravenous; D007362:Intensive Care Units; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage*
D014665:Vasodilator Agents; D001537:Bencyclane